Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progesterone, progestins and the breast in menopause treatment
Anne Gompel, Geneviève Plu‐Bureau
Climacteric (2018) Vol. 21, Iss. 4, pp. 326-332
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Management of menopause: a view towards prevention
Roger A. Lobo, Anne Gompel
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 6, pp. 457-470
Closed Access | Times Cited: 94
Menopause
Mary Jane Minkin
Obstetrics and Gynecology Clinics of North America (2019) Vol. 46, Iss. 3, pp. 501-514
Closed Access | Times Cited: 126
Menopausal hormone therapy and breast cancer risk
Serge Rozenberg, V. Di Pietrantonio, Jean Vandromme, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 6, pp. 101577-101577
Closed Access | Times Cited: 46
Relationship between menopausal hormone therapy and breast cancer: A nationwide population‐based cohort study
Jin‐Sung Yuk
International Journal of Gynecology & Obstetrics (2024) Vol. 166, Iss. 2, pp. 735-744
Closed Access | Times Cited: 6
A Contemporary View of Menopausal Hormone Therapy
Barbara Levy, James A. Simon
Obstetrics and Gynecology (2024)
Open Access | Times Cited: 4
Menopause: A Global Perspective and Clinical Guide for Practice
Amy J. Voedisch, Rebecca Dunsmoor-Su, Jennifer Kasirsky
Clinical Obstetrics & Gynecology (2021) Vol. 64, Iss. 3, pp. 528-554
Closed Access | Times Cited: 25
Hormones et cancers du sein
Anne Gompel
La Presse Médicale (2019) Vol. 48, Iss. 10, pp. 1085-1091
Open Access | Times Cited: 27
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study
Xiangyan Ruan, Muqing Gu, Guiju Cai, et al.
Maturitas (2019) Vol. 123, pp. 1-8
Closed Access | Times Cited: 25
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
John C. Stevenson, Serge Rozenberg, Silvia Maffei, et al.
Drugs in Context (2020) Vol. 9, pp. 1-12
Open Access | Times Cited: 20
Micronized progesterone, progestins, and menopause hormone therapy
M. Rodrigues, Anne Gompel
Women & Health (2020) Vol. 61, Iss. 1, pp. 3-14
Closed Access | Times Cited: 16
The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease
Jennifer L. Gordon, David R. Rubinow, Lana L. Watkins, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 105, Iss. 5, pp. e2050-e2060
Open Access | Times Cited: 12
PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study
Guiju Cai, Xiangyan Ruan, Muqing Gu, et al.
Gynecological Endocrinology (2020) Vol. 36, Iss. 11, pp. 1024-1027
Closed Access | Times Cited: 12
Simultaneous quantitation of 17 female sex hormones in illegal products by validated liquid chromatography‐high resolution mass spectrometry and liquid chromatography‐tandem mass spectrometry methods
Ji Hyun Lee, Min Kyeong Seo, Hyeon Joo Ham, et al.
Journal of Separation Science (2023) Vol. 46, Iss. 11
Closed Access | Times Cited: 3
Progestins in menopausal hormone therapy and breast cancer risk: The debate continues
Donita Africander, Renate Louw-du Toit
Current Opinion in Endocrine and Metabolic Research (2020) Vol. 15, pp. 24-30
Closed Access | Times Cited: 7
Perils of prolonged ovarian suppression and hypoestrogenism in the treatment of breast cancer: Is the risk of treatment worse than the risk of recurrence?
Robert P. Kauffman, Christina B. Young, V. Daniel Castracane
Molecular and Cellular Endocrinology (2021) Vol. 525, pp. 111181-111181
Closed Access | Times Cited: 7
Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia
Ibrahim Altedlawi Albalawi, Rashid Mir, Fasel M. Abu-Duhier
Endocrine Metabolic & Immune Disorders - Drug Targets (2019) Vol. 20, Iss. 5, pp. 760-770
Closed Access | Times Cited: 6
Comparison of Results between Topical Estrogen Treatment for Postmenopausal Vaginal Atrophy and Platelet-Rich Plasma Treatment
Ufuk Atlıhan, Can Ata, Hüseyin Aytuğ Avşar, et al.
Research Square (Research Square) (2024)
Open Access
Menopausal Hormone Therapy and breast cancer risk: Individualization is the key to safety
Eleni Armeni, Antonio Cano, Margaret Rees, et al.
Maturitas (2020) Vol. 141, pp. 85-86
Closed Access | Times Cited: 3
Le traitement hormonal de la ménopause en pratique. RPC Les femmes ménopausées du CNGOF et du GEMVi
A. Gosset, Geoffroy Robin, Brigitte Letombe, et al.
Gynécologie Obstétrique Fertilité & Sénologie  (2021) Vol. 49, Iss. 5, pp. 358-372
Closed Access | Times Cited: 3
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Yu Deng, Hongyan Jin
Cancer Biology and Medicine (2021) Vol. 19, Iss. 4, pp. 432-449
Open Access | Times Cited: 2
Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
Ana Paula Ferreira Costa, Ayane Cristine Alves Sarmento, Pedro Vieira‐Baptista, et al.
Frontiers in Reproductive Health (2021) Vol. 3
Open Access | Times Cited: 2
Hormone Therapy and Cancer
Anne Gompel
Cambridge University Press eBooks (2020), pp. 208-222
Closed Access | Times Cited: 1
Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer
JoAnn V. Pinkerton, Carolyn S. Wilson, Andrew M. Kaunitz
Menopause The Journal of The North American Menopause Society (2022) Vol. 29, Iss. 9, pp. 1001-1004
Closed Access | Times Cited: 1
Gestagengabe in der Menopause: Was sind Unterschiede, Vorteile und Nachteile der einzelnen Präparate?
Ursula Gobrecht-Keller
Journal für Gynäkologische Endokrinologie/Schweiz (2021) Vol. 24, Iss. 2, pp. 58-68
Open Access | Times Cited: 1
Terapia de reposição hormonal como possível agente intensificador da incidência de câncer de mama em mulheres no climatério / Hormone replacement therapy: a possible agent to enhance the incidence of breast cancer in women in climacteric
Thiago Dante Lustosa da Rocha Avelino, Antonio Carlos Pereira De Oliveira, Ana Laura Passos De Magalhães, et al.
Brazilian Journal of Health Review (2021) Vol. 4, Iss. 3, pp. 10390-10401
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top